News Bulletin
Friday, January 02 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
Friday, January 2, 2026 |
|
|||
|
9:45 |
S&P Global
Manufacturing PMI (Dec) |
51.8 |
51.8 |
52.2 |
|
|
Fed's Balance Sheet |
|
|
6,557B |
|
|
Reserve Balances with
Federal Reserve Banks |
|
|
2.934T |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
48,382.39 |
47,574.34 |
44,543.45 |
|
NASDAQ |
23,235.63 |
23,251.54 |
20,857.65 |
|
S&P 500 |
6,858.47 |
6,804.81 |
6,292.62 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
COMPANY |
EPS Act |
EPS
Fore |
Rev
Act |
Rev
Fore |
Mkt Cap |
Time |
|
Park Aerospace (PKE) |
-- |
-- |
-- |
-- |
420.21M |
|
|
Lifecore Biomedical (LFCR) |
-- |
-0.11 |
-- |
37.44M |
292.24M |
|
|
Hurco (HURC) |
-- |
-- |
-- |
-- |
97.27M |
|
|
Brookmount Explorations Inc (BMXI) |
-- |
-- |
-- |
-- |
11.56M |
|
Market
News:
More
Venezuela-bound oil tankers divert amid US seizure threats – Bloomberg : More oil tankers are turning away from
Venezuela as the US threatens to seize vessels transporting oil that helps fund
President Nicolas Maduro’s government.At
least seven ships have reversed course or halted at sea, according to ship
movements tracked Friday by Bloomberg. This adds to four other vessels that
turned away shortly after US forces boarded the vessel Skipper in mid-December.
General
Electric (GE) stock reached a 52-week high, climbing to
$318.07, just pennies away from its actual 52-week high of $318.06. This milestone
reflects a significant upward trend for the company, which has seen its stock
price increase by 83.75% over the past year, with an impressive 26.34% gain in
just the last six months.
Pinterest Inc (NYSE:PINS) stock rose 3% on Friday after The
Information predicted that OpenAI would acquire the
social media platform in 2026.
Norwegian
energy group Equinor filed a civil
suit in the U.S. District Court for the District of Columbia on Friday,
challenging a U.S. Department of the Interior order to suspend its Empire Wind
project.
BrightSpring Health Services, Inc. (BTSG):
Analyst David Larsen assigns a Buy rating with a $50 price target. The stock
has demonstrated a strong uptrend since summer, reaching new all-time highs.
While some consolidation may occur, BTIG believes further upside is likely as
long as it maintains support above its 50-day moving average of $34.43.
2Compass,
Inc. (COMP): With a Buy rating and $12.50 price target from
analyst Jake Fuller, this stock has shown remarkable recovery after declining
90% from 2021 to 2023. Following a multi-year base formation, it broke out in November.
BTIG sees good support in the $9-$9.50 range and projects potential upside to
$14 if support holds.
Compass,
Inc. reported strong third-quarter 2025 results with
revenue of $1.85 billion, a 23.6% year-over-year increase, and record adjusted
EBITDA of $93.6 million. Additionally, Barclays upgraded the company’s stock to
Overweight, citing synergies from its acquisition of HOUS.
Edwards
Lifesciences Corporation (EW):
Analyst Marie Thibault rates it Buy with a $103
target. After a significant gap down in mid-2024, the stock has steadily
recovered, filling the gap in November. Recent consolidation suggests another
leg higher into the mid-$90s, with potential to reach $105-$110 if it clears
the $95 level.
.
Establishment Lab Holdings, Inc. (ESTA): Carrying an
$86 price target from analyst Sam Eiber, this stock broke out in October/November and is now
consolidating below $80. BTIG maintains a constructive outlook as long as
support at $62-$64 holds.
Harrow,
Inc. (HROW): Analyst Thomas Shrader
assigns a $63 target. After a strong run followed by a pullback in early 2025,
the stock has been recovering. BTIG believes it could challenge its previous
high around $59, with support in the low $40s offering potential buying opportunities.Harrow, Inc. reported a third-quarter 2025
earnings per share of $0.33, beating forecasts, and also completed its
acquisition of clinical-stage pharmaceutical company Melt Pharmaceuticals.
Klaviyo, Inc. (KVYO): With a $40 target from analyst Nick Altmann, this stock has been forming a base for the past
year with a potential double bottom around $23. Having reclaimed its 200-day
moving average, it faces resistance at $35-$37, but could run to $40-$50 if it
breaks through.
For
internal use only